Pacific Sun Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
BP
Pacific Sun Financial's PBE Position: Q3 2026 in Review
Pacific Sun Financial held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q3 2026 at 3,662 shares worth $356K. The position accounts for 0.14% of the portfolio, ranked #161.
Pacific Sun Financial first reported a position in PBE in Q1 2018 and has held it in 28 quarters since. The position peaked at $752K in Q2 2018. 111 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- Pacific Sun Financial held 3,662 shares of Invesco Biotechnology & Genome ETF worth $356K as of Q3 2026.
- Pacific Sun Financial left its Invesco Biotechnology & Genome ETF share count unchanged in Q3 2026.
- Invesco Biotechnology & Genome ETF made up 0.14% of Pacific Sun Financial's portfolio in Q3 2026, its #161 holding.
- Pacific Sun Financial first reported a position in Invesco Biotechnology & Genome ETF in Q1 2018 and has held it in 28 quarters since.
- Pacific Sun Financial's Invesco Biotechnology & Genome ETF position peaked at $752K in Q2 2018.
- 111 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on Pacific Sun Financial's 13F filing for Q3 2026, filed 13 Nov 2026.